SHSE:688273's Gross Margin % is ranked better than 79.01% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.03
vs SHSE:688273: 69.23
Nanjing Medlander Medical Technology Co had a gross margin of 66.92% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Nanjing Medlander Medical Technology Co (SHSE:688273) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Nanjing Medlander Medical Technology Co had a gross margin of 66.92% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Nanjing Medlander Medical Technology Co Gross Margin % Related Terms
Nanjing Medlander Medical Technology Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nanjing Medlander Medical Technology Co Gross Margin % Chart
Nanjing Medlander Medical Technology Co Annual Data
SHSE:688273 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Nanjing Medlander Medical Technology Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nanjing Medlander Medical Technology Co Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nanjing Medlander Medical Technology Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Nanjing Medlander Medical Technology Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Nanjing Medlander Medical Technology Co (SHSE:688273) has a Gross Margin % of 66.92% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Nanjing Medlander Medical Technology Co and its competitors. This is near median its historical median of 72.45. Over the past decade, Nanjing Medlander Medical Technology Co's Gross Margin % has ranged from 68.55 to 80.25. According to the industry distribution chart, Nanjing Medlander Medical Technology Co ranks #169 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 21%.
Is Nanjing Medlander Medical Technology Co's Gross Margin % too high?
Nanjing Medlander Medical Technology Co's current Gross Margin % of 66.92% is near median its 10-year median of 72.45. Over the past 10 years, this metric has ranged from a low of 68.55 to a high of 80.25. The Medical Devices & Instruments industry median Gross Margin % is 52.03. Nanjing Medlander Medical Technology Co's value of 66.92% is 28.6% above this industry median. Based on the distribution chart, Nanjing Medlander Medical Technology Co ranks #169 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Nanjing Medlander Medical Technology Co has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nanjing Medlander Medical Technology Co's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nanjing Medlander Medical Technology Co ranks #169 out of 805 companies for Gross Margin %. This places Nanjing Medlander Medical Technology Co in the top 21% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.03. Nanjing Medlander Medical Technology Co's value of 66.92% is 28.6% above this benchmark. Historically, Nanjing Medlander Medical Technology Co's own Gross Margin % has ranged from 68.55 to 80.25 over the past decade. While the company's 10-year median is 72.45 vs. the industry median of 52.03, Nanjing Medlander Medical Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.03, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nanjing Medlander Medical Technology Co's current Gross Margin % of 66.92% is 28.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Nanjing Medlander Medical Technology Co and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nanjing Medlander Medical Technology Co's current Gross Margin % is 66.92%, which is near median its own 10-year median of 72.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanjing Medlander Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Nanjing Medlander Medical Technology Co (SHSE:688273) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥34.95, compared to a current price of ¥40.65 — trading 16.3% above its estimated fair value. The current Gross Margin % is 66.92%, which is near median its 10-year median of 72.45 and 28.6% above the Medical Devices & Instruments industry median of 52.03. Nanjing Medlander Medical Technology Co's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Nanjing Medlander Medical Technology Co (SHSE:688273), the current Gross Margin % is 66.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nanjing Medlander Medical Technology Co (SHSE:688273) Overvalued in 2026?
Based on GuruFocus' analysis, Nanjing Medlander Medical Technology Co stock appears to be overvalued.
The current stock price of ¥40.65 is trading 16.3% above its estimated GF Value™ of ¥34.95.
GuruFocus considers Nanjing Medlander Medical Technology Co to be Modestly Overvalued.
Key valuation signals for SHSE:688273:
Gross Margin %: 66.92% (near median its 10-year median of 72.45)
GF Value™: ¥34.95 vs. price of ¥40.65 (16.3% above fair value)
Industry Position: 28.6% above the Medical Devices & Instruments median (#169 of 805)
No single metric tells the full story. See the SHSE:688273 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nanjing Medlander Medical Technology Co Business Description
Nanjing Medlander Medical Technology Co Ltd is engaged in the research and development, production, sales, and service of related products in the field of pelvic floor and postpartum rehabilitation. Its products mainly include: biostimulation feedback instrument, color ultrasound diagnosis and evaluation system, magnetic stimulator, high-frequency evaluation electrocautery instrument, pelvic floor training instrument, portable postpartum recovery instrument, home pelvic floor rehabilitation therapy instrument, etc., which are widely used in obstetrics and gynecology, pelvic floor rehabilitation center, urology, anorectal department and other hospital departments.
79GF Score
Get the complete analysis for SHSE:688273
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688273 has been successfully added to your 
